Table 2.
(A) Overall IL28B genotype frequency | |||
---|---|---|---|
IL28B genotype frequency | Overall | Treated | Not treated |
| |||
Recipient* | (n=171) | (n=67) | (n=104) |
CC | 56 (33%) | 22 (33%) | 34 (33%) |
CT | 87 (51%) | 33 (49%) | 54 (52%) |
TT | 28 (16%) | 12 (18%) | 16 (15%) |
Undetermined | 18 | 10 | 8 |
HWE**, Ψ2 P-value | 0.55 | ||
Donor* | (n=172) | (n=74) | (n=98) |
CC | 80 (47%) | 33 (45%) | 47 (48%) |
CT | 72 (42%) | 36 (49%) | 36 (37%) |
TT | 20 (12%) | 5 (7%) | 15 (15%) |
Undetermined | 17 | 3 | 14 |
HWE**, Ψ2 P-value | 0.54 | ||
Donor vs recipient, Ψ2 P-value | 0.0305 |
(B), Paired recipient:donor IL28B genotype frequency | |||
---|---|---|---|
IL28B genotype frequency | Overall | Treated | Not treated |
| |||
(n=155) | (n=65) | (n=90) | |
Donor non-CC : Recipient non-CC | 52 (34%) | 19 (29%) | 33 (37%) |
Donor CC : Recipient non-CC | 50 (32%) | 24 (37%) | 26 (29%) |
Donor non-CC : Recipient CC | 29 (19%) | 15 (23%) | 14 (16%) |
Donor CC : Recipient CC | 24 (15%) | 7 (11%) | 17 (19%) |
IL28B genotype was not determined from 18 recipients and 17 donor livers
HWE = Hardy-Weinberg equilibrium